A prospective study of bloodstream infections among febrile adolescents and adults attending Yangon General Hospital, Yangon, Myanmar.
Journal
PLoS neglected tropical diseases
ISSN: 1935-2735
Titre abrégé: PLoS Negl Trop Dis
Pays: United States
ID NLM: 101291488
Informations de publication
Date de publication:
04 2020
04 2020
Historique:
received:
04
07
2019
accepted:
03
04
2020
revised:
12
05
2020
pubmed:
1
5
2020
medline:
1
7
2020
entrez:
1
5
2020
Statut:
epublish
Résumé
Data on causes of community-onset bloodstream infection in Myanmar are scarce. We aimed to identify etiological agents of bloodstream infections and patterns of antimicrobial resistance among febrile adolescents and adults attending Yangon General Hospital (YGH), Yangon, Myanmar. We recruited patients ≥12 years old with fever ≥38°C who attended YGH from 5 October 2015 through 4 October 2016. A standardized clinical history and physical examination was performed. Provisional diagnoses and vital status at discharge was recorded. Blood was collected for culture, bloodstream isolates were identified, and antimicrobial susceptibility testing was performed. Using whole-genome sequencing, we identified antimicrobial resistance mechanisms of Enterobacteriaceae and sequence types of Enterobacteriaceae and Streptococcus agalactiae. Among 947 participants, 90 (9.5%) had bloodstream infections (BSI) of which 82 (91.1%) were of community-onset. Of 91 pathogens isolated from 90 positive blood cultures, we identified 43 (47.3%) Salmonella enterica including 33 (76.7%) serovar Typhi and 10 (23.3%) serovar Paratyphi A; 20 (22.0%) Escherichia coli; 7 (7.7%) Klebsiella pneumoniae; 6 (6.6%), Staphylococcus aureus; 4 (4.4%) yeasts; and 1 (1.1%) each of Burkholderia pseudomallei and Streptococcus agalactiae. Of 70 Enterobacteriaceae, 62 (88.6%) were fluoroquinolone-resistant. Among 27 E. coli and K. pneumoniae, 18 (66.6%) were extended-spectrum beta-lactamase (ESBL)-producers, and 1 (3.7%) each were AmpC beta-lactamase- and carbapenemase-producers. Fluoroquinolone resistance was associated predominantly with mutations in the quinolone resistance-determining region. blaCTX-M-15 expression was common among ESBL-producers. Methicillin-resistant S. aureus was not detected. Fluoroquinolone-resistant, but not multiple drug-resistant, typhoidal S. enterica was the leading cause of community-onset BSI at a tertiary hospital in Yangon, Myanmar. Fluoroquinolone and extended-spectrum cephalosporin resistance was common among other Enterobactericeae. Our findings inform empiric management of severe febrile illness in Yangon and indicate that measures to prevent and control enteric fever are warranted. We suggest ongoing monitoring and efforts to mitigate antimicrobial resistance among community-onset pathogens.
Identifiants
pubmed: 32352959
doi: 10.1371/journal.pntd.0008268
pii: PNTD-D-19-01004
pmc: PMC7217485
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0008268Déclaration de conflit d'intérêts
The authors have declared that they have no competing interests.
Références
Emerg Infect Dis. 2017 May;23(5):857-859
pubmed: 28418298
mBio. 2018 Feb 20;9(1):
pubmed: 29463654
J Clin Microbiol. 2016 Nov;54(11):2695-2700
pubmed: 27558182
Nat Med. 2006 Jan;12(1):83-8
pubmed: 16369542
Clin Microbiol Rev. 2014 Oct;27(4):647-64
pubmed: 25278570
Trans R Soc Trop Med Hyg. 2019 Oct 11;113(10):641-648
pubmed: 31225619
J Antimicrob Chemother. 2016 Feb;71(2):563-5
pubmed: 26542305
Southeast Asian J Trop Med Public Health. 2002 Dec;33(4):764-71
pubmed: 12757224
Clin Infect Dis. 2011 Jul 15;53(2):114-23
pubmed: 21690617
JAMA. 2016 Feb 23;315(8):762-74
pubmed: 26903335
Nucleic Acids Res. 2015 Feb 18;43(3):e15
pubmed: 25414349
Int J Antimicrob Agents. 2014 Jul;44(1):30-7
pubmed: 24831713
PLoS One. 2015 Jun 30;10(6):e0127962
pubmed: 26126200
Ann Intern Med. 2002 Nov 19;137(10):791-7
pubmed: 12435215
PLoS One. 2017 Sep 14;12(9):e0184720
pubmed: 28910381
Pediatrics. 2006 Jun;117(6):e1139-45
pubmed: 16682492
EMBO Rep. 2001 Nov;2(11):958-63
pubmed: 11713181
PLoS One. 2008 May 21;3(5):e2188
pubmed: 18493312
Trans R Soc Trop Med Hyg. 2014 Nov;108(11):692-8
pubmed: 25253617
Cochrane Database Syst Rev. 2008 Oct 08;(4):CD006083
pubmed: 18843701
Clin Infect Dis. 2012 Oct;55(8):1107-13
pubmed: 22752519
PLoS Negl Trop Dis. 2017 Feb 27;11(2):e0005376
pubmed: 28241011
Antimicrob Agents Chemother. 2014 Dec;58(12):7611-2
pubmed: 25246390
Am J Trop Med Hyg. 2006 Nov;75(5):978-85
pubmed: 17124000
Curr Opin Infect Dis. 2008 Oct;21(5):531-8
pubmed: 18725804
J Clin Microbiol. 2005 May;43(5):2510-2
pubmed: 15872298
J Intern Med. 1998 Nov;244(5):379-86
pubmed: 9845853
Nat Ecol Evol. 2017 Jun 19;1:193
pubmed: 29388565
Front Microbiol. 2016 Nov 23;7:1881
pubmed: 27933044
Lancet Infect Dis. 2012 Jun;12(6):480-7
pubmed: 22632186
Microb Drug Resist. 2017 Jan;23(1):79-82
pubmed: 27096168
J Infect Dis. 1999 Jul;180(1):87-92
pubmed: 10353865
Front Microbiol. 2012 Jan 19;3:9
pubmed: 22294983
Clin Infect Dis. 2017 May 15;64(suppl_2):S145-S152
pubmed: 28475781
Antimicrob Agents Chemother. 2016 Oct 21;60(11):6795-6805
pubmed: 27600040
Clin Infect Dis. 2013 Mar;56(5):641-8
pubmed: 23150211
Clin Microbiol Infect. 2012 Mar;18(3):268-81
pubmed: 21793988
Emerg Infect Dis. 2001 Mar-Apr;7(2):302-5
pubmed: 11294729
Antimicrob Agents Chemother. 2009 Jun;53(6):2643-5
pubmed: 19289526
J Antimicrob Chemother. 2017 Jan;72(1):273-280
pubmed: 27624571
Am J Trop Med Hyg. 2014 Jun;90(6):1043-6
pubmed: 24710616
Int J Parasitol. 2005 Oct;35(11-12):1319-31
pubmed: 16102769
J Microbiol Immunol Infect. 2005 Dec;38(6):436-43
pubmed: 16341345
Eur J Clin Microbiol Infect Dis. 2016 Jun;35(6):927-33
pubmed: 26993288
Int J Infect Dis. 2017 Jan;54:62-63
pubmed: 27894983
Microb Drug Resist. 2018 Nov;24(9):1333-1344
pubmed: 29565227
Int J Antimicrob Agents. 2018 Dec;52(6):771-782
pubmed: 30312654
Chest. 2003 May;123(5):1615-24
pubmed: 12740282
Clin Infect Dis. 2005 Sep 15;41(6):839-47
pubmed: 16107984
J Clin Microbiol. 2017 Apr;55(4):1116-1121
pubmed: 28100599
Genome Announc. 2015 Apr 09;3(2):
pubmed: 25858833
J Glob Health. 2012 Jun;2(1):010401
pubmed: 23198130
Foodborne Pathog Dis. 2011 Feb;8(2):255-60
pubmed: 21117922
Am J Trop Med Hyg. 2012 Feb;86(2):246-253
pubmed: 22302857
BMJ. 2006 Jul 8;333(7558):78-82
pubmed: 16825230
Gut Pathog. 2011 Aug 09;3(1):12
pubmed: 21827661
Vaccine. 2016 May 17;34(23):2622-6
pubmed: 27026150
Antimicrob Agents Chemother. 2011 Dec;55(12):5952-4
pubmed: 21930874
PLoS One. 2013;8(3):e59775
pubmed: 23555777
Antimicrob Agents Chemother. 2019 Dec 20;64(1):
pubmed: 31636071
Clin Infect Dis. 2019 Mar 7;68(Suppl 2):S124-S129
pubmed: 30845332
Public Health Nutr. 2018 Dec 18;:1-14
pubmed: 30561292